克洛斯特里迪奥伊德困难感染:预防和治疗策略
Elvira Ingrid Levy1, Meltem Dinleyici2, Ener Dinleyici3
1Department of Pediatrics, C.H.U. Saint-Pieter, Free University of Brussels, Brussels, Belgium.
Advances in experimental medicine and biology
|July 26, 2024
概括
困难菌感染是与抗生素相关的腹的日益严重的原因,可以通过便微生物群移植来治疗. 萨卡罗米塞斯·布拉尔迪 (Saccharomyces boulardii) CNCM I-745在预防C. difficile感染方面显示出有前途的作用.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 胃肠病学 胃肠病学
背景情况:
- 在全球范围内,Clostridioides difficile是导致与抗生素相关的腹的主要原因.
- 感染范围从无症状到危及生命的,在社区和医院环境中增加.
- 目前的疗法包括抗菌药物停用,抗生素和便微生物群移植.
研究的目的:
- 对Clostridioides difficile感染的当前和新兴疗法进行审查.
- 突出益生菌,特别是Saccharomyces boulardii CNCM I-745在预防中的作用.
- 为了确定关于儿科Clostridioides difficile治疗的研究差距.
主要方法:
- 关于Clostridioides difficile治疗现有研究的文献综述.
- 对便微生物群移植疗效数据的分析.
- 评估益生菌的使用,特别是Saccharomyces boulardii CNCM I-745,用于预防.
主要成果:
- 便微生物种移植是针对复发性C. difficile感染的一种成熟治疗方法.
- 萨卡罗米塞斯·布拉尔迪 (Saccharomyces boulardii) CNCM I-745是一种公认的预防疗法.
- 目前还没有关于先进疗法的数据,例如小儿群体的微生物向治疗或疫苗.
结论:
- 虽然成年人对C. difficile的治疗方法正在进步,但儿童年龄组仍未得到充分研究.
- 需要进一步的研究来开发和验证针对儿童的新疗法.
- 萨卡罗米塞斯·布拉尔迪 (Saccharomyces boulardii) CNCM I-745提供了一个预防性选择,用于C. difficile.
相关概念视频
Transmission-based Precautions I: Contact, Enteric, and Droplets
3.5K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
3.5K
Healthcare Associated Infections II: Preventive Measures
2.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.6K
Inflammatory Bowel Disease IV: Pharmacological Management
124
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
124
Drugs for Treatment of Diarrhea-Predominant IBS
156
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
156
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
149
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
149
Inflammatory Bowel Disease V: Surgical Management
138
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
138


